Virginia Commonwealth University-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2024

  1. Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study

    American Journal of Preventive Cardiology, Vol. 17

2021

  1. Incidence, Management, Immediate and Long-Term Outcome of Guidewire and Device Related Grade III Coronary Perforations (from G3CAP - Cardiogroup VI Registry)

    American Journal of Cardiology, Vol. 143, pp. 37-45

  2. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

  2. Tailoring adjuvant endocrine therapy for premenopausal breast cancer

    New England Journal of Medicine, Vol. 379, Núm. 2, pp. 122-137

2017

  1. Fatal anaphylaxis caused by gadolinium due to beta-tryptase–induced hemorragic diathesis

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 5, Núm. 5, pp. 1433-1434

2015

  1. Adjuvant ovarian suppression in premenopausal breast cancer

    New England Journal of Medicine, Vol. 372, Núm. 5, pp. 436-446

  2. An international survey on taking up a career in cardiovascular research: Opportunities and biases toward would-be physician-scientists

    PLoS ONE, Vol. 10, Núm. 7

  3. High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: A meta-analysis

    Atherosclerosis, Vol. 240, Núm. 1, pp. 197-204

2014

  1. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

    New England Journal of Medicine, Vol. 371, Núm. 2, pp. 107-118

  2. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

    Journal of Hepatology

  3. Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States

    Thrombosis research, Vol. 134, Núm. 3, pp. 558-564

2010

  1. Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis

    Transplantation, Vol. 89, Núm. 1, pp. 69-74

  2. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients

    Clinical Infectious Diseases, Vol. 51, Núm. 9, pp. 1062-1069

2008

  1. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis

    Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 2, pp. 735-738

  2. Central nervous system cryptococcosis in solid organ transplant recipients: Clinical relevance of abnormal neuroimaging findings

    Transplantation, Vol. 86, Núm. 5, pp. 647-651

  3. Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen

    Clinical Infectious Diseases, Vol. 46, Núm. 2

2007

  1. Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality

    Journal of Infectious Diseases, Vol. 195, Núm. 5, pp. 756-764

2005

  1. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome

    Transplantation, Vol. 80, Núm. 8, pp. 1131-1133

  2. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients

    Clinical Infectious Diseases, Vol. 40, Núm. 12, pp. 1756-1761